Two-helper RNA system for production of recombinant Semliki forest virus particles.
about
DENV inhibits type I IFN production in infected cells by cleaving human STINGInhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complexAlphavirus-based vaccinesA Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid ParticlesSindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice.Nairovirus RNA Sequences Expressed by a Semliki Forest Virus Replicon Induce RNA Interference in Tick CellsSindbis Virus Vectors Designed To Express a Foreign Protein as a Cleavable Component of the Viral Structural PolyproteinIncorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell LineSequestration of G3BP coupled with efficient translation inhibits stress granules in Semliki Forest virus infectionProbing the functional equivalence of otoferlin and synaptotagmin 1 in exocytosis.Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest Virus replication complexes from the plasma membrane to modified lysosomes.A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha.An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells.Importance of eIF2alpha phosphorylation and stress granule assembly in alphavirus translation regulationEarly alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particleBiochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus.In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs.Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccinesKinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizationsHumoral responses against coimmunized protein antigen but not against alphavirus-encoded antigens require alpha/beta interferon signalingThe adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon.A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.Assembly of alphavirus replication complexes from RNA and protein components in a novel trans-replication system in mammalian cells.Alphaviruses in gene therapyNeoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.Viral alteration of cellular translational machinery increases defective ribosomal products.Novel antigen delivery systems.Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System.Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.Semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma.Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.Differential Phosphatidylinositol-3-Kinase-Akt-mTOR Activation by Semliki Forest and Chikungunya Viruses Is Dependent on nsP3 and Connected to Replication Complex Internalization.Viral and Synthetic RNA Vector Technologies and Applications.Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout.Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation.
P2860
Q21131391-5B8765B7-4224-4FE6-A01D-D364623D2E1FQ24611465-C9C0719A-AB93-41BF-8CF6-99E0CCE615FBQ26994724-5AA005ED-5A0D-426C-B6E6-FD4FFDE17ADBQ27339522-CA916B07-0109-4898-90E6-FADDD6FEB1E6Q27469315-1ABFCD13-8032-43FC-8C71-38C9227C4343Q27470017-ADFA75B4-702B-4D3D-A95B-A7C0DBBA80EFQ27473478-2EA61771-A66D-46BC-A984-A21F0F7B99AAQ27477708-66DCD477-7B20-45A5-A3D5-145CB92BB2C8Q30009987-2B6B122B-47A8-433C-A223-9AB3EAAA87C3Q30474026-76F85D43-ABDD-4711-B779-F059831D5B17Q30495294-90BD1A2F-B83D-4314-B549-F184085EF13FQ33733874-F67CA6B3-3A43-4602-BBBC-5E8FB4625874Q33788131-2EA92BE0-9319-4E18-8071-3137DBE9D4BCQ33835188-E9DD4655-78FD-414C-9F0D-8A4B43733AFCQ33911149-7E12DFF4-8A82-4B72-975D-AABF7E3EF61EQ33911908-F881BB0D-2DB6-4E3B-BBB9-61FEF42A5FAAQ33925772-CBEB220A-B7FC-4033-A897-A91DF71AA71CQ33930424-CB01CF3F-D3F6-48FC-A339-56B07EB92B45Q33964113-94B6BE1D-7321-4476-91B2-8BD34438C31DQ34573907-DB321ECA-DA74-4F4D-85BB-FAD4162180C4Q34593874-1C51C0FD-8E28-4C2B-9D99-59B4D25D82FBQ34717846-B67902DD-C3F1-4E4C-AB05-BB7D22A4FCCEQ34778787-169E7A4B-512F-4BBB-9B1F-F347906E1214Q35018332-E8D0BF65-87F8-40CD-AB23-492C99F42CCFQ35076756-BF687470-3F00-465E-9328-7B4911DBD108Q35259499-B1DEC620-DB92-4AC5-8681-89CFD3C5639DQ35766493-478E4AC3-93BE-41B1-9241-4B7795559E77Q35913706-AC91389A-2FDF-46C7-83CF-BD06179338D0Q35914423-8D96DA8F-1F33-4C3C-A294-AE131DAB3C93Q35947894-A161568A-AB54-4F26-A4A7-BE318C1F9E5DQ36220613-6ED5D8D0-8A70-4278-8819-4DE72125C032Q36255413-09A80219-068F-4E3F-8D4B-297EFAEA31EEQ36759944-F45288E0-4ECA-4BA8-AD48-262DB22B347DQ37349246-7DE53C51-0743-4046-A052-25D334CE83C6Q37452091-004673ED-BDFF-443F-8215-04EAF5BC396AQ37711813-8063D82E-2DD3-4625-8BE9-83B3A79A9DB7Q38838063-86B21B89-3EBE-47F8-9E9B-09019386F8ADQ38885624-F014873F-DECD-42A7-86C3-34607D3399E0Q39125742-539DB357-6ACF-4435-9DE2-5085EBAE1D7CQ39230468-106A6EA9-2F54-4757-B819-FBCE68AF04EB
P2860
Two-helper RNA system for production of recombinant Semliki forest virus particles.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@en
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@nl
type
label
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@en
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@nl
prefLabel
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@en
Two-helper RNA system for production of recombinant Semliki forest virus particles.
@nl
P2860
P1433
P1476
Two-helper RNA system for production of recombinant Semliki forest virus particles
@en
P2093
P Liljeström
P2860
P304
P407
P577
1999-02-01T00:00:00Z